Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Hanover - Delayed Quote • EUR Pfizer Inc (PFE.HA) Follow Compare 24.93 -0.20 (-0.82%) At close: February 28 at 5:25:29 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds? We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best vaccine store stocks to buy now. What Will Trump’s Tariffs Mean for the Pharma Industry? On February 24, […] Pfizer quietly made some big DEI changes Pfizer (PFE) made some major changes to its diversity, equity, and inclusion (DEI) webpage on Thursday, joining other major American corporations that have recently aligned themselves closer with the Trump administration. Q4 2024 Codexis Inc Earnings Call Q4 2024 Codexis Inc Earnings Call Q4 2024 OPKO Health Inc Earnings Call Q4 2024 OPKO Health Inc Earnings Call Is Pfizer Inc. (PFE) the Best Retirement Stock to Buy According to Hedge Funds? We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best retirement stocks to buy according to hedge funds. After much suspense, the US Federal Reserve finally began cutting interest rates […] Pfizer’s bet on gene therapies in haemophilia has been a bust The company's exit from the gene therapy space has reduced the competition for eligible interested patients. Is Pfizer Inc. (PFE) the Best Stock Under $50 to Buy Right Now? We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks. From a certain perspective, domestic equities are off to a strong start this year. Despite a large selloff on February […] Novavax reports large quarterly revenue declines, rethinks its strategic direction Novavax closed up the day it reported a pivot in direction. Jim Cramer Believes That Pfizer (PFE) Can Leverage Its COVID Role To Create A Working Relationship With President Trump We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer recalled the stock market crash due to the […] Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting earnings tomorrow after the bell. Here’s what to look for. Why Summit Therapeutics Inc. (SMMT) Went Down On Monday? We recently published a list of 10 Stocks Drop The Most Amid Investor Caution. In this article, we are going to take a look at where Summit Therapeutics Inc. (NASDAQ:SMMT) stands against other stocks that drop the most amid investor caution. Wall Street kicked off the first trading day of the week on a sour […] Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer SMMT's Q4 results meet estimates. The company signs a deal with Pfizer that expands ivonescimab's development beyond the NSCLC indication. Pfizer's (NYSE:PFE) earnings have declined over three years, contributing to shareholders 34% loss In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market... The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO Alibaba, Pfizer, MercadoLibre and SIFCO are included in this Analyst Blog. Q4 2024 Summit Therapeutics Inc Earnings Call Q4 2024 Summit Therapeutics Inc Earnings Call Summit Therapeutics Inc (SMMT) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... Summit Therapeutics Inc (SMMT) reports a robust cash reserve and debt-free status, while advancing key clinical trials and partnerships. Top Research Reports for Alibaba, Pfizer & MercadoLibre Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE) and MercadoLibre, Inc. (MELI), as well as a micro-cap stock SIFCO Industries, Inc. (SIF). Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department. Pfizer sets sights on Summit’s bispecific in combo with its ADCs Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer. Summit Therapeutics Stock Sinks as Firm Reports Widening Loss Summit Therapeutics shares are dropping Monday morning as it reported a fourth-quarter adjusted loss nearly double that of the prior year. It also announced a collaboration with Pfizer. Performance Overview Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return PFE.HA S&P 500 YTD -0.54% +1.24% 1-Year +7.12% +17.45% 3-Year -31.21% +36.14%